beta-Lapachone CAS: 4707-32-8
MF: C15H14O3
β-Lapachone is a selective DNA topoisomerase I inhibitor.

β-Lapachone (CAS 4707-32-8)

β-Lapachone | CAS 4707-32-8 is rated 5.0 out of 5 by 1.
  • y_2021, m_6, d_15, h_18
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.17
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_200875, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 128ms
  • REVIEWS, PRODUCT
loading
5
1
4
0
3
0
2
0
1
0
Alternate Names: 3,4-Dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran-5,6-dione
Application: β-Lapachone is a selective DNA topoisomerase I inhibitor
CAS Number: 4707-32-8
Purity: ≥98%
Molecular Weight: 242.27
Molecular Formula: C15H14O3
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data (including water content).
loading

β-Lapachone, a novel Topo I (topoisomerase I) inhibitor, does not stabilize the cleavable complex indicating a novel mode of action, unlike camptothecin (sc-200871). Apoptosis has been demonstrated in HL-60 and human prostate cancer cells treated with β-Lapachone via a p53-independent mechanism and cell cycle arrest at G0/G1,2. β-Lapachone has been observed to accelerate wound healing by increasing cell proliferation in cells such as: keratinocytes, fibroblasts and endothelial while also increasing the migration of fibroblasts and endothelial cells. β-Lapachone has exhibited anti-inflammatory properties by suppressing the NF-κB activation by blocking IκBα degradation and downregulating the ERK, p38 mitogen-activated protein kinase and Akt pathway.


References

1. Planchon, S M., et al., 1995. Beta-lapachone-mediated apoptosis in human promyelocytic leukemia (HL-60) and human prostate cancer cells: a p53-independent response. Cancer research. 55(17): 3706-11. PMID: 7641180
2. Li, C J., et al., 1993. beta-Lapachone, a novel DNA topoisomerase I inhibitor with a mode of action different from camptothecin. The Journal of biological chemistry. 268(30): 22463-8. PMID: 8226754
3. Choi, Byung Tae., et al., 2003. beta-Lapachone-induced apoptosis is associated with activation of caspase-3 and inactivation of NF-kappaB in human colon cancer HCT-116 cells. Anti-cancer drugs. 14(10): 845-50. PMID: 14597880
4. Moon, Dong-Oh., et al., 2007. Anti-inflammatory effects of beta-lapachone in lipopolysaccharide-stimulated BV2 microglia. International immunopharmacology. 7(4): 506-14. PMID: 17321474
5. Kung, Hsiu-Ni., et al., 2008. In vitro and in vivo wound healing-promoting activities of beta-lapachone. American journal of physiology. Cell physiology. 295(4): C931-43. PMID: 18650264
6. Dong, Guang Zhi., et al., 2010. Beta-lapachone suppresses radiation-induced activation of nuclear factor-kappaB. Experimental & molecular medicine. 42(5): 327-34. PMID: 20200474

Usage :
Store, as supplied, at room temperature for up to 1 year. Store solutions at - 20°C for up to 3 months.
Physical State :
Solid
Solubility :
Soluble in DMSO (>25 mg/ml), ethanol (20 mg/ml), chloroform, and DMF.
Storage :
Store at -20° C
Melting Point :
~151-153° C (dec.)
Boiling Point :
~381.4° C at 760 mmHg (Predicted)
Density :
1.25 g/cm3 (Predicted)
Refractive Index :
n20D 1.60
Optical Activity :
α20/D -43.9°, c = 2 in water
IC50 :
HIV-1 LTR: IC50 = 0.3 µM (human); HOS: IC50 = 1400 nM (human); MDA-MB-435 : IC50 = 0.06 ug.mL-1 (human); HL-60: IC50 = 1650 nM (human)
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
WGK Germany :
3
RTECS :
QL6127400
PubChem CID :
MDL Number :
MFCD01712233
Beilstein Registry :
0181499
SMILES :
CC1(CCC2=C(O1)C3=CC=CC=C3C(=O)C2=O)C

Download SDS (MSDS)

Certificate of Analysis

Adobe Acrobat Reader is required to reliably view,
print and comment on PDF documents

beta-Lapachone (CAS 4707-32-8)  Product Citations

See how others have used beta-Lapachone (CAS 4707-32-8). Click on the entry to view the PubMed entry .

Citations 1 to 7 of 7 total

PMID: # 17609380  Bey, EA. et al. 2007. Proc. Natl. Acad. Sci. USA. 104: 11832-11837.

PMID: # 15044484  Lin, MT et al. 2004. J Biol Chem. 279: 24015-23.

PMID: # 12598645  Li, Y. et al. 2003. Proc. Natl. Acad. Sci. U.S.A. 100: 2674-2678.

PMID: # 9927052  Shiah, SG. et al. 1999. Cancer Res. 59: 391-398.

PMID: # 2740334  Boothman, DA. et al. 1989. Proc. Natl. Acad. Sci. U.S.A. 86: 4963-4967.

PMID: # 29298345  PLoS ONE. 13: e0190717.

PMID: # 33360352  Redox Biol. 101840.

Citations 1 to 7 of 7 total
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 100ms
  • QUESTIONS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
Rated 5 out of 5 by from Bey et al Bey et al. (PubMed ID 17609380) used -Lapachone, a proven chemotherapeutic and radiosensitizing agent, to selectively destroy non-small-cell lung cancer (NSCLCs) cells with abnormally high expression of NQO1. -SCBT Publication Review
Date published: 2015-04-20
  • y_2021, m_6, d_15, h_18
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.17
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_200875, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 15ms
  • REVIEWS, PRODUCT